Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001651308-21-000146
Filing Date
2021-07-01
Accepted
2021-07-01 16:55:32
Documents
3
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_162517288122252.html 3  
1 FORM 3 wf-form3_162517288122252.xml 3 5190
2 JULIA WANG - POA powerofattorneyjwang.htm EX-24 4871
3 JWANG - POA powerofattorneyjwang001.jpg GRAPHIC 251703
  Complete submission text file 0001651308-21-000146.txt   358358
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Issuer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVE, CAMANA BAY, PO BOX 1348 GRAND CAYMAN E9 KY1-1108
Business Address
Wang Julia Aijun (Reporting) CIK: 0001860279 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37686 | Film No.: 211066698